Mergers & Acquisitions

Filter

Current filters:

None

Popular Filters

804 to 828 of 914 results

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Global biotechnology market set to exceed $320 billion by 2015, says GIA

25-01-2012

The biotechnology industry was adversely affected by the global financial crisis, with several leading…

BiotechnologyGlobalMarkets & MarketingMergers & AcquisitionsResearch

Roche makes $5.7 billion hostile bid for Illumina

25-01-2012

Swiss drugs and diagnostic major Roche (ROG: SIX) announced this morning that it is proposing to acquire…

IlluminaMergers & AcquisitionsPharmaceuticalRoche

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

OPKO Health to acquire Chilean drugmaker; buys cancer tests

24-01-2012

Florida, USA-based OPKO Health (NYSE: OPK) had a busy day yesterday, entering into a definitive agreement…

ALS DistribuidoraEuropeMergers & AcquisitionsOPKO HealthPharmaceuticalSouth America

XOMA acquires US rights to perindopril franchise

18-01-2012

California, USA-based XOMA Corp (Nasdaq: XOMA) says it has acquired US rights to the perindopril franchise…

AceonCardio-vascularMergers & AcquisitionsperindoprilPharmaceuticalServierXOMA Corp

Roche in epigenetics drug discovery collaboration

18-01-2012

USA-based Constellation Pharmaceuticals says that it has entered into a major strategic agreement with…

BiotechnologyConstellation PharmaceuticalsGenentechLicensingMergers & AcquisitionsOncologyPharmaceuticalRoche

Pharma M&A in 2011 surges back to pre-recession levels

18-01-2012

As the global pharmaceutical industry faces a third (35%) of its 20 best-selling prescription medicines’…

LicensingMergers & AcquisitionsPharmaceutical

India’s Dishman buys French company

17-01-2012

Indian drugmaker Dishman Pharmaceuticals and Chemicals says that its Swiss unit has acquired a contract…

CréapharmGenericsMergers & Acquisitions

Valeant ups its bid for ISTA Pharma

17-01-2012

California, USA-based ophthalmology and allergy drug company ISTA Pharmaceuticals (Nasdaq: ISTA) says…

ISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalRespiratory and PulmonaryValeant Pharmaceuticals

Merck & Co out to lead in hepatitis C

12-01-2012

US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company’s…

Anti-viralsMerck & CoMergers & AcquisitionsPharmaceuticalResearch

2011 a bumper year for Pharma, Biotech and Generics M&A

11-01-2012

Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011

11-01-2012

Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

Shire gets US Rights to Resolor

10-01-2012

Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

Ownership change for BioLigands ApS

09-01-2012

The founding shareholders in BioLigands ApS together with UK based biotech Bridge BioResearch have taken…

BioLigandsMergers & AcquisitionsPharmaceutical

Bristol-Myers to buy hep C drug developer for $2.5 billion

09-01-2012

Looking to bolster its drug pipeline in the face of US patent expiry of one of its best selling drugs,…

Anti-viralsBristol-Myers SquibbInhibitexMergers & AcquisitionsPharmaceutical

Smith & Nephew to spin-out biologics and clinical therapies unit

05-01-2012

Texas, USA-based venture capital firm Essex Woodlands has entered into a strategic partnership with the…

BiotechnologyBioventusMergers & AcquisitionsSmith & Nephew

Cornerstone acquires Cardiokine

04-01-2012

US specialty drugmaker Cornerstone Therapeutics (Nasdaq: CRTX) said yesterday that it has acquired Cardiokine,…

Cardio-vascularCardiokineCornerstone TherapeuticslixivaptanMergers & AcquisitionsMetabolicsPharmaceutical

Accelrys acquires VelQuest for $35 million

04-01-2012

Scientific enterprise R&D software and services company Accelrys (Nasdaq: ACCL) says that it has acquired…

AccelrysMergers & AcquisitionsPharmaceuticalResearchVelQuest

STADA pulls out of part of Grunenthal deal

04-01-2012

German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

Biotech predictions for 2012 from sector specialist Steven Burrill

03-01-2012

As 2011 drew to a close, Steven Burrill, chief executive of global life sciences financial services firm…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegulation

Alexion to buy Enobia Pharma for potential $1 billion

30-12-2011

US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) has reached agreement to acquire privately held Canadian…

Alexion Pharmaceuticalsasfotase alfaEnobia PharmaMergers & AcquisitionsPharmaceuticalRare diseases

804 to 828 of 914 results

Back to top